THE PHARMACOLOGY OF PARKINSONS-DISEASE - L-DOPA AND BEYOND

被引：7
|
作者：
RIEDERER, P
REYNOLDS, GP
JELLINGER, K
机构：
[1] MED SCH CAMBRIDGE,MRC,NEUROCHEM PHARMACOL UNIT,CAMBRIDGE CB2 2QH,ENGLAND
[2] MED SCH CAMBRIDGE,MRC,BRAIN TISSUE BANK,CAMBRIDGE CB2 2QH,ENGLAND
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 1984年 / 5卷 / 01期
关键词：
D O I：
10.1016/0165-6147(84)90355-9
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：25 / 27
页数：3
相关论文
共 50 条
  • [21] JUVENILE PARKINSONS-DISEASE AND ITS RESPONSE TO L-DOPA THERAPY
    ASKENASY, JJM
    MENDELSON, L
    KEREN, O
    BRAUN, Z
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1990, 2 (01) : 23 - 30
  • [22] SLEEP IN PATIENTS WITH PARKINSONS-DISEASE AND ITS INFLUENCE BY L-DOPA
    SCHNEIDER, E
    MAXION, H
    ZIEGLER, B
    JACOBI, P
    JOURNAL OF NEUROLOGY, 1974, 207 (02) : 95 - 108
  • [23] SEROTONERGIC NEURONS ARE NOT INVOLVED IN ACTION OF L-DOPA IN PARKINSONS-DISEASE
    MELAMED, E
    HEFTI, F
    LIEBMAN, J
    SCHLOSBERG, AJ
    WURTMAN, RJ
    NATURE, 1980, 283 (5749) : 772 - 774
  • [24] L-DOPA IMPROVES COLOR-VISION IN PARKINSONS-DISEASE
    BUTTNER, T
    KUHN, W
    PATZOLD, T
    PRZUNTEK, H
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1994, 7 (01) : 13 - 19
  • [25] LONG-TERM RESULTS WITH L-DOPA IN PARKINSONS-DISEASE
    BARBEAU, A
    UNION MEDICALE DU CANADA, 1975, 104 (01): : 32 - 38
  • [26] TREATMENT OF PARKINSONS-DISEASE WITH ORPHENADRINE ALONE AND IN COMBINATION WITH L-DOPA
    BASSI, S
    ALBIZZATI, MG
    CALLONI, E
    SBACCHI, M
    FRATTOLA, L
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1986, 40 (07): : 273 - 275
  • [27] SPEECH CHANGES IN PARKINSONS-DISEASE DURING TREATMENT WITH L-DOPA
    WOLFE, VI
    GARVIN, JS
    BACON, M
    WALDROP, W
    JOURNAL OF COMMUNICATION DISORDERS, 1975, 8 (03) : 271 - 279
  • [28] UNUSUAL SYMPTOMS IN PARKINSONS-DISEASE - POSITIVE EFFECTS OF L-DOPA
    MORELMAROGER, A
    THERME, F
    THERAPIE, 1978, 33 (01): : 129 - 130
  • [29] ENTERIC-COATED L-DOPA (PRODOPA) - NEW APPROACH TO L-DOPA THERAPY IN PARKINSONS-DISEASE
    GILLIGAN, B
    HANCOCK, R
    MEDICAL JOURNAL OF AUSTRALIA, 1975, 2 (22) : 824 - 826
  • [30] L-DOPA METHYL-ESTER - A CANDIDATE FOR CHRONIC SYSTEMIC DELIVERY OF L-DOPA IN PARKINSONS-DISEASE
    COOPER, DR
    MARREL, C
    TESTA, B
    VANDEWATERBEEMD, H
    QUINN, N
    JENNER, P
    MARSDEN, CD
    CLINICAL NEUROPHARMACOLOGY, 1984, 7 (01) : 89 - 98
12345